Sign Up
Sign in
en
ru
News
Foundation
Technopark
Город
Education
Search
/
News
/
Пресс-релизы
/
Subscribe via RSS
RSS for posts
RSS for comments
Articles
News
Press Releases
Press Review
Photos
Opinions
Video
Subscribe
To new posts in this blog
Skoltech’s Center for Entrepreneurship and Innovation Makes Pivotal Step to Enrich Russia’s Entrepreneurship and Innovation Ecosystem
The Center for Entrepreneurship and Innovation (CEI) at the Skolkovo Institute of Science and Technology (Skoltech) has announced an international call for proposals for postdoctoral research projects...
12.03.2013
The Russian Startup Tour Begins
In Yekaterinburg, the first stage of the Russian Startup Tour, a unique 17-city road show and initiative of the the Skolkovo Foundation, has finished. Support for the Russian Startup Tour is provided by...
07.03.2013
Official Statement
Regarding the statement by the Investigative Committee of the Russian Federation, which alleges that funds allocated for the creation of the Innovation Center "Skolkovo" were misused, the "Skolkovo"...
01.03.2013
MIT Technology Review and Open Innovations Forum in Moscow Announce Knowledge Collaboration
MIT Technology Review, an independent media company founded at Massachusetts Institute of Technology, becomes a Knowledge Producer for the Open Innovations Forum, the premier summit for technology, investment...
22.02.2013
The Skolkovo resident News360 was awarded as the best world startup at the World Summit Award – Mobile Content
The Skolkovo Foundation resident, a Russian-American company News360 was awarded yesterday as the best project in M-media and News nomination of a prestigious world contest World Summit Award – Mobile...
06.02.2013
NeuroMax, a Skolkovo resident company, successfully completes first phase of clinical trials for diabetic neuropathy drug
NeuroMax has successfully completed Phase Ia clinical trials on the safety and pharmacokinetics of drug candidate NM-IA-001 (BNV-222) for patients with diabetic neuropathy. Previously approved by the Ministry...
30.01.2013
New Year Greetings from Victor Vekselberg
Dear colleagues! I don’t think anybody really believed that life on Earth will stop after December 21. How can people aimed at formation of the future trust in a doomsday? How can we run out of energy...
27.12.2012
Maxwell Biotech Venture Fund’s Portfolio Company Infectex Enrolls First Patients in Pivotal Clinical Trial of SQ109 for Multi-Drug Resistant Tuberculosis (MDR-TB)
Infectex, a Russian biotech company in Maxwell Biotech Venture Fund’s portfolio announced today enrollment of the first patients in its Phase IIb-III clinical trial of SQ109 for MDR-TB. Infectex...
19.12.2012
TEDxSkolkovo.NewVision in hypercubes in Skolkovo
TEDx@Skolkovo NEW VISION will take place on Saturday, December 15th in Skolkovo Hypecube (Moscow, Russia). The independently organized event is licensed by TED. In the modern world technologies are booming...
14.12.2012
Foresight Science & Technology and Skolkovo Technopark Sign MOU
November 10, 2012, Providence, RI - Foresight Science and Technology Incorporated, a global consultancy with operations in metropolitan Boston and San Francisco plus Oxford England,Singapore, and Santiago...
04.12.2012
<
>